ADHD medication errors jumped 300% since 2000
The researchers wrote that the increased prescribing of these medications is likely the reason for the significant rise in ADHD medication errors over the past two decades.
Stay updated with breaking news from Camber Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The researchers wrote that the increased prescribing of these medications is likely the reason for the significant rise in ADHD medication errors over the past two decades.
To embed, copy and paste the code into your website or blog: Earlier this month, Eric Sagonowsky reviewed the top ten drugs in the U.S. (in terms of sales) losing patent exclusivity in an article published by These drugs are Lucentis (Genentech/Roche), Bystolic (AbbVie/Allergan), Vascepa (Amarin), Nothera (Lundbeck), Narcan (Emergent Biosolutions), Brovana (Sunovion), Sutent (Pfizer), Saphris (AbbVie/Allergan), Amitiza (Mallinckrodt), and Feraheme (Amag Pharma). The nature of these losses and consequences thereof can be seen from the article, synopsized here. Lucentis (ranibizumab), Roche'...